Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are currently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $15.18.
A number of research analysts recently issued reports on the stock. Truist Financial decreased their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Thursday, November 14th. Oppenheimer dropped their price objective on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 13th. Piper Sandler decreased their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 13th. Finally, Craig Hallum dropped their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th.
Check Out Our Latest Report on IAS
Insider Activity
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Integral Ad Science in the 2nd quarter valued at $4,724,000. Nisa Investment Advisors LLC boosted its holdings in shares of Integral Ad Science by 449,805.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company’s stock worth $4,154,000 after buying an additional 427,315 shares during the last quarter. abrdn plc grew its position in Integral Ad Science by 12.5% during the third quarter. abrdn plc now owns 2,147,656 shares of the company’s stock valued at $23,216,000 after buying an additional 237,930 shares during the period. Invenomic Capital Management LP increased its holdings in Integral Ad Science by 57.4% during the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock worth $6,327,000 after buying an additional 213,488 shares during the last quarter. Finally, Rice Hall James & Associates LLC bought a new stake in Integral Ad Science in the third quarter worth about $1,795,000. 95.78% of the stock is currently owned by hedge funds and other institutional investors.
Integral Ad Science Stock Down 0.4 %
Integral Ad Science stock opened at $10.58 on Friday. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $17.53. The stock has a market cap of $1.72 billion, a P/E ratio of 52.90, a P/E/G ratio of 1.49 and a beta of 1.45. The company’s 50-day moving average price is $11.14 and its two-hundred day moving average price is $10.66. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. Integral Ad Science’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.09) earnings per share. As a group, analysts expect that Integral Ad Science will post 0.26 EPS for the current year.
About Integral Ad Science
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
- Five stocks we like better than Integral Ad Science
- What is a Secondary Public Offering? What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Texas Instruments: The Old-School Tech Titan Still Delivering
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.